Lung cancer therapeutics market projected to reach $59.5B by 2031, growing at 10.5% CAGR, driven by immunotherapy advances and increased global R&D funding. https://www.einpresswire.com/article/816442877/lung-cancer-therapeutics-market-accelerates-amid-innovation-policy-support-and-r-d-deals-datam-intelligence